Depression

A new study analyzed the adherence to guidelines and associated factors for timely follow-up and minimal treatment for patients with depression identified by screening in primary care.
Read More

Unemployment and home ownership may be associated with treatment prognosis in patients with depression.
Read More

A nonresponse to esketamine nasal spray plus oral antidepressants in the first week of treatment does not predict failure of response at 4 weeks.
Read More

Mothers with postpartum depression had significant improvement in symptoms 12 weeks after taking a 1-day online cognitive behavioral therapy workshop.
Read More

Discontinuing antidepressant therapy significantly increased the risk of relapse among patients in primary care practices who felt well enough to stop taking antidepressants.
Read More

Adding lithium to usual care did not reduce the risk of a repeated suicide-related event in veterans with major depression or bipolar disorder who had survived a previous event.
Read More

An investigational drug for postpartum depression was associated with improvements in core symptoms of depression and maternal functioning.
Read More

Results of a recent study show that antidepressant prescription fills during pregnancy were associated with a small decrease in standardized test scores in children for mathematics but not for language.
Read More

The psychedelic compound psilocybin was not more effective than the antidepressant escitalopram in reducing symptoms of depression in patients with moderate-to-severe major depressive disorder.
Read More

Six weeks of 10-minute sessions using a smartphone app reduced depressive symptoms in patients with diabetes or hypertension in Brazil and Peru, according to 2 recent randomized clinical trials.
Read More

Subscribe to Value-Based Care in Neurology

Stay up to date with the latest news in neurology by subscribing to receive the free VBCN e‑Newsletter.